GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy

Kidney International

Volumn 73, Issue 12, 2008, Pages 1426-1433

  Van Es, L A ^a   De Heer, E ^a   Vleming, L J ^a   Van Der Wal, A ^a   Mallat, M ^a   Bajema, I ^a   Bruijn, J A ^a   De Fijter, J W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell mediated immunity; Cytotoxic T lymphocytes; GMP 17; IgA nephropathy; Progression; Tubulitis

Indexed keywords

GRANULE MEMBRANE PROTEIN 17; HLA DR ANTIGEN; LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FIBROBLAST; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY TUBULE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MESANGIUM CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SCORING SYSTEM; T LYMPHOCYTE;

EID: 44449124219     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.66     Document Type: Article

References (16)

1. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196.
2. Geddes CC, Rauta V, Gronhagen-Riska C et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003; 18: 1541-1548.
3. Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002; 13: 142-148.
4. Pozzi C, Andrulli S, Del Vecchio L et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 2004; 15: 157-163.
5. Risdon RA, Sloper JC, De Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968; 2: 363-366.
6. Bohle A, Mackensen-Haen S, von Gise H et al. The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 1990; 186: 135-144.
7. D'Amico G, Ferrario F, Rastaldi MP. Tubulointerstitial damage in glomerular diseases: its role in the progression of renal damage. Am J Kidney Dis 1995; 26: 124-132.
8. Anderson P. TIA-1: structural and functional studies on a new class of cytolytic effector molecule. Curr Top Microbiol Immunol 1995; 198: 131-143.
9. Medley QG, Kedersha N, O'Brien S et al. Characterization of GMP-17, a granule membrane protein that moves to plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci USA 1996; 93: 685-689.
10. Russell GJ, Nagler-Anderson C, Anderson P et al. Cytotoxic potential of intraepithelial lymphocytes (IELs). Presence of TIA-1, the cytolytic granule-associated protein, in human IELs in normal and diseased intestine. Am J Pathol 1993; 143: 350-354.
11. Myllymaki JM, Honkanen TT, Syrjanen JT et al. Severity of tubulointerstitial inflammation and prognosis in immunoglobulin A nephropathy. Kidney Int 2007; 71: 343-348.
12. Alexopoulos E, Seron D, Hartley RB et al. The role of interstitial infiltrates in IgA nephropathy: a study with monoclonal antibodies. Nephrol Dial Transplant 1989; 4: 187-195.
13. Heller F, Lindenmeyer MT, Cohen CD et al. The contribution of B Cells to renal interstitial inflammation. Am J Pathol 2007; 170: 457-468.
14. Levey AS, Greene T, Kusek J et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
15. Mitch WE, Walser M, Buffington GA et al. A simple method of estimating progression of chronic renal failure. Lancet 1976; 2: 1326-1328.
16. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.